EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2022
CVR: 32770487
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -57,917,073 and a net result of DKK -79,149,270 compared with DKK -27,224,687 the year before. Equity in the 2022 report amounted to DKK 68,531,910. The solvency ratio was 75.3%. The company had 27 employees in the financial year.
- Gross Profit
- DKK -57,917,073
- Profit/Loss
- DKK -79,149,270
- Equity
- DKK 68,531,910
- Total Assets
- DKK 91,017,389
- Employees
- 27
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -57.9M | -79.1M | 68.5M | 27 |
| 2021 | - | -7.8M | -27.2M | 97.3M | 21 |
| 2020 | - | -7M | -18.4M | 64.3M | 16 |
| 2019 | - | 2.8M | -8.6M | -3.7M | 15 |
| 2018 | - | 510K | -9.8M | -14.3M | 15 |
Official annual report
Keep an eye on EXPRES2ION BIOTECHNOLOGIES ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 6, 2022, Allan Rosetzsky has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2021. Gross profit came to DKK -7,806,372, and the net result was DKK -27,224,687.
About EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.